Prevention of Amyloidosis in Familial Mediterranean Fever with Colchicine: A Case-Control Study in Armenia
Medical Principles and Practice, 10/05/2009
Sevoyan MK et al. – The study demonstrated that colchicine treatment is effective in preventing amyloidosis among Armenian patients with FMF and that earlier initiation and continuous ... amyloidosis risk among Armenian patients with FMF. Methods - The study included 99 Armenian patients from the Center of Medical Genetics database with genetically ascertained FMF; 33 had renal amyloidosis and 66 were randomly selected control patients without renal amyloidosis ... with incident amyloidosis were more likely to be older men, but younger at the time of disease onset, and more likely to have had a family history of amyloidosis and M694F mutation in the MEFV gene compared to patients without amyloidosis.
- The risk of amyloidosis decreased with adequate ... than interrupted use, earlier rather than later initiation age of colchicine treatment, current colchicine rather than ever/never colchicine use.
[more...]
|
A case with rheumatoid arthritis and systemic reactive AA amyloidosis showing rapid regression of amyloid deposition on gastroduodenal mucosa after a combined therapy of corticosteroid and etanercept
Rheumatology International, 10/16/2009
|
Ishii W et al. – Systemic reactive amyloid A (AA) amyloidosis is one of the critical complications associated with ... AA amyloidosis patients. This is the first case report of RA–related systemic reactive AA amyloidosis histopathologically demonstrating rapid regression of amyloid deposits on gastroduodenal mucosa after adequate suppression of the underlying inflammatory condition.
[more...]
|
Unusual Combination of Tracheobronchopathia Osteochondroplastica and AA Amyloidosis
Yonsei Medical Journal, 10/29/2009
|
Kirbas G et al. – This case illustrates that it is possible for TO and amyloidosis to masquerade as asthma. TO and amyloidosis should be suspected in patients of older ages with asthma and especially with ... and lateral tracheobronchial walls are typical for TO, a biopsy should be obtained to exclude amyloidosis.
[more...]
|
Vitreous Amyloidosis in Two Sisters as the Indication of Transthyretin-Related Familial Form of Systemic Amyloidosis Among Liver Transplantation Candidates
Transplantation Proceedings, 11/12/2009
|
Niemczyk R et al. – The authors have presented 2 sisters with involvement of the vitreous body, which prompted a subsequent diagnosis of ... ndash;related, familial form of systemic amyloidosis. Due to the progressive character of the disease and poor prognosis, the patients have been considered for liver transplantation, which at present is the only treatment option for this disease.
[more...]
|
Cystatin C is a sensitive marker for detecting a reduced glomerular filtration rate when assessing chronic kidney disease in patients with rheumatoid arthritis and secondary amyloidosis
Scandinavian Journal of Rheumatology, 10/02/2009
|
Sato H et al. – Serum cysC can identify a reduced GFR more accurately than sCr-eGFRs. Serum cysC > 1.09 mg/L could be a marker of a reduced GFR, and serum cysC > 1.365 mg/L would strongly suggest a reduced GFR in patients who have RA with secondary amyloidosis. 50 patients with RA and secondary amyloidosis (mean age 60.9 ± 11.2 years; 45 women) were evaluatedRevised 24-h creatinine clearance (r24-hCCr), was determined by multiplying original value by 0.719, used as reference for GFRScreening potential of serum cysC and ... ROC) curve analyses of reduced GFR, serum cysC gave a greater area under curve than the sCr-eGFR Specificity and PPV 100% when serum cysC > 1.365 mg/L was used
[more...]
|
Effective anti-tnf-î± therapy can induce rapid resolution and sustained decrease of gastroduodenal mucosal amyloid deposits in reactive amyloidosis associated with rheumatoid arthritis
Journal of Rheumatology, 10/09/2009
Kuroda T et al. –This study examined the effect of anti-tumor necrosis factor-? (anti-TNF) therapy in patients with reactive AA amyloidosis associated with RA. Our results indicate a striking ... deposits in gastric mucosal tissue with amelioration of renal functions in patients with reactive amyloidosis due to RA Methods- 14 patients with reactive AA amyloidosis associated with RA were prospectively evaluated
- Mean period of anti-TNF therapy 20.1 ± 13.8 mos
[more...]
|
Classification of amyloidosis by laser microdissection and mass spectrometry based proteomic analysis in clinical biopsy specimens
Blood, 10/09/2009
|
Vrana JA et al. – LMD/MS identified the amyloid type with 100% specificity and sensitivity in the training set and was conclusive in 98% of the validation set ... enhance our ability to type amyloidosis accurately in clinical biopsy specimens.
[more...]
|
Left Ventricular Ejection Time on Echocardiography Predicts Long-Term Mortality in Light Chain Amyloidosis
Journal of the American Society of Echocardiography, 11/04/2009
|
Migrino RQ et al. – AL amyloidosis was associated with high long–term mortality. Among echocardiographic and clinical parameters, only ET and alkaline phosphatase had incremental ... patients.
[more...]
|
Marked shrinkage of amyloid lymphadenopathy after an intensive chemotherapy in a patient with IgM-associated AL amyloidosis
Amyloid The Journal of Protein Folding Disorders, 11/20/2009
|
Tazawa KI et al. – A male patient with primary AL amyloidosis who had been suffering from systemic lymphadenopathy with IgM?–type M–proteinemia received two ... by autologous peripheral blood stem cell transplantation. Deposits of AL amyloid may regress from the tissue if the chemotherapy succeeds in persistent inhibition of the production of an amyloidogenic immunoglobulin light chain.
[more...]
|
Localised retroperitoneal amyloidosis mimicking retroperitoneal fibrosis: a rare cause of obstructive uropathy
Singapore Medical Journal, 10/02/2009
|
Banerji JS et al. – The authors present this case due to the rarity of localised retroperitoneal amyloidosis as a cause of obstructive uropathy.
[more...]
|